EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Susceptibility to hypertension based on MTHFR rs1801133 single nucleotide polymorphism and MTHFR promoter methylation

Ming-Huang Chiu, Chia-Hsiu Chang, Disline Manli Tantoh, Tsui-Wen Hsu, Chih-Hsuan Hsiao, Ji-Han Zhong, Yung-Po Liaw

Frontiers in Cardiovascular Medicine · 02.10.2023 · 10

DOI: 10.3389/fcvm.2023.1159764 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 02.10.2023. Verfasst von Ming-Huang Chiu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology and Respiratory Care, Cathay General Hospital, Taipei City, Taiwan. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The aetio-pathologenesis of hypertension is multifactorial, encompassing genetic, epigenetic, and environmental factors. The combined effect of genetic and epigenetic changes on hypertension is not known. We evaluated the independent and interactive association of MTHFR rs1801133 single nucleotide polymorphism (SNP) and MTHFR promoter methylation with hypertension among Taiwanese adults.

Methods

We retrieved data including, MTHFR promoter methylation, MTHFR rs1801133 genotypes (CC, CT, and TT), basic demography, personal lifestyle habits, and disease history of 1,238 individuals from the Taiwan Biobank (TWB).

Results

The distributions of hypertension and MTHFR promoter methylation quartiles (β < 0.1338, 0.1338 ≤ β < 0.1385, 0.1385 ≤ β < 0.1423, and β ≥ 0.1423 corresponding to <Q1, Q1–Q2, Q2–Q3, and ≥Q3) among individuals with the rs1801133 genotypes (CC, CT, and TT) were significantly different ( P < 0.05). The risk of hypertension was significantly higher among individuals with the TT genotype compared to the reference genotype (CC): odds ratio (OR); 95% confidence interval (CI) = 2.718; 1.503–4.914. The trend of the association of the CT and TT genotypes with hypertension was dose-dependent ( P-trend = 0.0041). MTHFR promoter methylation (lower quartiles compared to ≥Q3) was not significantly associated with hypertension. However, its interaction with MTHFR rs1801133 was significant ( P = 0.0323). After stratification by rs1801133 genotypes, lower MTHFR promoter methylation quartiles (<Q1, Q1–Q2, Q2–Q3) compared to ≥Q3 were significantly associated with a higher risk of hypertension among individuals carrying the CC genotype: ORs (95% CIs) = 3.225 (1.140–9.124), 4.177 (1.424–12.247), and 8.645 (2.513–29.739) for Q2–Q3, Q1–Q2, and <Q1, respectively. The trend test was significant ( P-trend = 0.0009).

Conclusion

Independently, rs1801133 TT was associated with a higher risk of hypertension, but methylation was not. Based on genotypes, lower methylation was dose-dependently associated with a higher risk of hypertension in individuals with the CC genotype. Our findings suggest that MTHFR rs1801133 and MTHFR promoter methylation could jointly influence hypertension susceptibility.

Schlagwörter

Stichwörter der Autor:innen

MTHFRhypertensioninteractionpromoter methylationrs1801133susceptibility

Autor:innen und Institutionen

  • Department of Pulmonology and Respiratory Care, Cathay General Hospital, Taipei City, Taiwan.
  • Cardiovascular Center, Cathay General Hospital, Taipei City, Taiwan.
  • Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung City, Taiwan.
  • Department of Public Health and Institute of Public Health, Chung Shan Medical University, Taichung City, Taiwan.
  • Superintendent Office, Institute of Medicine, Cathay General Hospital, Taipei City, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung City, Taiwan.

Zitieren

APA

Chiu, M. H., Chang, C. H., Tantoh, D. M., Hsu, T. W., Hsiao, C. H., Zhong, J. H., & Liaw, Y. P. (2023). Susceptibility to hypertension based on MTHFR rs1801133 single nucleotide polymorphism and MTHFR promoter methylation. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1159764

Vancouver

Chiu MH, Chang CH, Tantoh DM, Hsu TW, Hsiao CH, Zhong JH, et al. Susceptibility to hypertension based on MTHFR rs1801133 single nucleotide polymorphism and MTHFR promoter methylation. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1159764

BibTeX
@article{Chiu2023,
  author = {Chiu, Ming-Huang and Chang, Chia-Hsiu and Tantoh, Disline Manli and Hsu, Tsui-Wen and Hsiao, Chih-Hsuan and Zhong, Ji-Han and Liaw, Yung-Po},
  title = {Susceptibility to hypertension based on MTHFR rs1801133 single nucleotide polymorphism and MTHFR promoter methylation},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1159764}
}
Kostenlos starten →